CCS-1477
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
p300/CBP
Description:
CCS-1477 is a selective and small-molecule inhibitor of p300/CBP (Kd = 1.3/1.7 nM). Study in vivo showed that it had the ability to suppress the prostate tumour growth via lowering AR and AR-splice variants and the cancer regulator c-Myc. CCS-1477 is promisingly developed to be a novel drug for the treatment of prostate cancer.
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
inhibitor of p300/CBP, prostate cancer
MSDS:
Inquire
Application:
the potential treatment of prostate cancer
Current Developer:
CellCentric
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Quick Inquiry

Verification code

Featured Items